Who Paid My Doc
Paul Slosar
Orthopaedic Surgery of the Spine Daly City, CA Medical Doctor
NPI 1417929548 CMS profile 18376
455 Hickey Blvd Ste 310, Ste 310, Daly City, CA 94015
General payments
$3,059,939
Research payments
$33,750
Ownership & investment interest
$15,679
Through program year 2025, Paul Slosar of Daly City, CA is reported in the CMS Open Payments database as having received $3,059,939 across 588 general payments and $33,750 in research payments paid to them. They also declared ownership or investment interests valued at $15,679 across 3 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
11 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $293,741 | 62 | |
| 2024 | General | $341,352 | 69 | |
| 2023 | General | $414,400 | 82 | |
| 2022 | General | $346,617 | 97 | |
| 2022 | Research | $33,750 | 1 | |
| 2021 | General | $1,151,395 | 109 | |
| 2020 | General | $471,938 | 149 | |
| 2019 | General | $40,496 | 20 | |
| 2022 | Ownership | $10,679 | 1 | |
| 2021 | Ownership | $3,000 | 1 | |
| 2020 | Ownership | $2,000 | 1 |
Beside peers
- Paul Slosar
- Orthopaedic Surgery of the Spine median
- Middle half of Orthopaedic Surgery of the Spine
- National median
In program year 2025, general payments to Paul Slosar were reported at $293,741. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.
Show as a table
| Year | Paul Slosar | Orthopaedic Surgery of the Spine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $40,496 | $2,106 | $337–$18,608 | $163 |
| 2020 | $471,938 | $1,213 | $156–$15,082 | $114 |
| 2021 | $1,151,395 | $1,834 | $271–$15,617 | $132 |
| 2022 | $346,617 | $2,015 | $320–$17,036 | $149 |
| 2023 | $414,400 | $1,925 | $336–$14,599 | $160 |
| 2024 | $341,352 | $2,110 | $341–$12,483 | $164 |
| 2025 | $293,741 | $2,061 | $347–$14,651 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
589 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Orthopaedic Surgery of the Spine in California
Hyun Bae
Orthopaedic Surgery of the Spine · Santa Monica, CA
Choll Kim
Orthopaedic Surgery of the Spine · San Diego, CA
Stacey Bederman
Orthopaedic Surgery of the Spine · Orange, CA
Gregory Mundis
Orthopaedic Surgery of the Spine · La Jolla, CA
Babak Barcohana
Orthopaedic Surgery of the Spine · Van Nuys, CA
Neelakantan Anand
Orthopaedic Surgery of the Spine · Los Angeles, CA
Related records
Orthopaedic Surgery of the Spine in California
Practitioners in the same specialty and state, ranked by reported value.
All Orthopaedic Surgery of the Spine
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.